TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Aprea Therapeutics AB
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
0
|
191
|
165 |
Financial expenses |
0
![]() |
0
![]() |
0 |
Earnings before taxes |
-5,392
|
-61,926
|
-111,581 |
EBITDA |
-5,662
|
-61,903
|
-114,235 |
Total assets |
17,503
|
17,860
|
60,714 |
Current assets |
17,397
|
17,754
|
60,483 |
Current liabilities |
7,985
|
9,508
|
42,883 |
Equity capital |
9,518
|
8,352
|
16,744 |
- share capital |
9,518
![]() |
9,518
![]() |
9,518 |
Employees (average) |
1
|
6
|
9 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
54.4%
|
46.8%
|
27.6% |
Turnover per employee |
0
|
32
|
18 |
Profit as a percentage of turnover |
-32422.0%
|
-67624.8% | |
Return on assets (ROA) |
-30.8%
|
-346.7%
|
-183.8% |
Current ratio |
217.9%
|
186.7%
|
141.0% |
Return on equity (ROE) |
-56.7%
|
-741.5%
|
-666.4% |
Change turnover |
-191
|
26
|
6 |
Change turnover % |
-100%
|
16%
|
4% |
Chg. No. of employees |
-5
|
-3
|
0 |
Chg. No. of employees % |
-83%
|
-33%
|
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.